Talis Biomedical Corp Stock Market Value
| TLIS Stock | USD 2.84 0.00 0.00% |
| Symbol | Talis |
Talis Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Talis Biomedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Talis Biomedical.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Talis Biomedical on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Talis Biomedical Corp or generate 0.0% return on investment in Talis Biomedical over 90 days. Talis Biomedical Corporation operates as a molecular diagnostic company More
Talis Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Talis Biomedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Talis Biomedical Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0923 | |||
| Maximum Drawdown | 77.5 |
Talis Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Talis Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Talis Biomedical's standard deviation. In reality, there are many statistical measures that can use Talis Biomedical historical prices to predict the future Talis Biomedical's volatility.| Risk Adjusted Performance | 0.0831 | |||
| Jensen Alpha | 1.06 | |||
| Total Risk Alpha | 0.0285 | |||
| Treynor Ratio | (0.71) |
Talis Biomedical January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0831 | |||
| Market Risk Adjusted Performance | (0.70) | |||
| Mean Deviation | 2.32 | |||
| Coefficient Of Variation | 993.33 | |||
| Standard Deviation | 9.67 | |||
| Variance | 93.5 | |||
| Information Ratio | 0.0923 | |||
| Jensen Alpha | 1.06 | |||
| Total Risk Alpha | 0.0285 | |||
| Treynor Ratio | (0.71) | |||
| Maximum Drawdown | 77.5 | |||
| Skewness | 7.83 | |||
| Kurtosis | 63.1 |
Talis Biomedical Corp Backtested Returns
Talis Biomedical is extremely dangerous given 3 months investment horizon. Talis Biomedical Corp owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.13, which indicates the firm had a 0.13 % return per unit of risk over the last 3 months. We were able to collect and analyze data for seventeen different technical indicators, which can help you to evaluate if expected returns of 1.25% are justified by taking the suggested risk. Use Talis Biomedical Corp Risk Adjusted Performance of 0.0831, variance of 93.5, and Coefficient Of Variation of 993.33 to evaluate company specific risk that cannot be diversified away. Talis Biomedical holds a performance score of 10 on a scale of zero to a hundred. The entity has a beta of -1.35, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Talis Biomedical are expected to decrease by larger amounts. On the other hand, during market turmoil, Talis Biomedical is expected to outperform it. Use Talis Biomedical Corp information ratio and rate of daily change , to analyze future returns on Talis Biomedical Corp.
Auto-correlation | 0.00 |
No correlation between past and present
Talis Biomedical Corp has no correlation between past and present. Overlapping area represents the amount of predictability between Talis Biomedical time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Talis Biomedical Corp price movement. The serial correlation of 0.0 indicates that just 0.0% of current Talis Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.14 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Talis Pink Sheet Analysis
When running Talis Biomedical's price analysis, check to measure Talis Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talis Biomedical is operating at the current time. Most of Talis Biomedical's value examination focuses on studying past and present price action to predict the probability of Talis Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talis Biomedical's price. Additionally, you may evaluate how the addition of Talis Biomedical to your portfolios can decrease your overall portfolio volatility.